Property:LoE
Appearance
This is a property of type Text.
The allowed values for this property are:
- 1a Oxford 2009
- 1b Oxford 2009
- 1c Oxford 2009
- 2a Oxford 2009
- 2b Oxford 2009
- 2c Oxford 2009
- 3a Oxford 2009
- 3b Oxford 2009
- 4 Oxford 2009
- 5 Oxford 2009
- Level 1 Oxford 2011
- Level 2 Oxford 2011
- Level 3 Oxford 2011
- Level 4 Oxford 2011
- Level 5 Oxford 2011
- -
- ?
D
2b Oxford 2009 +
E
Ehrenpreis et al. (2005): A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Retinol Palmitate (Vitamin A) for Symptomatic Chronic Radiation Proctopathy +
2b Oxford 2009 +
Emami et al. (2014): Double-blinded, randomized, placebo-controlled study to evaluate the effectiveness of green tea in preventing acute gastrointestinal complications due to radiotherapy +
2b Oxford 2009 +
Ertekin et al. (2004): Zinc sulfate in the prevention of radiation-induced oropharyngeal mucositis: a prospective, placebo-controlled, randomized study +
2b Oxford 2009 +
F
Fahimi et al. (2011): Evaluating the Effect of Zingiber Officinalis on Nausea and Vomiting in Patients Receiving Cisplatin Based Regimens +
Level 2 Oxford 2011 +
Fallahi et al. (2013): Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer? +
2b Oxford 2009 +
Fallon et al. (2017) I: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies +
Level 2 Oxford 2011 +
Fallon et al. (2017) II: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies +
Level 2 Oxford 2011 +
Ferreira et al. (2004): Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: A double-blind randomized trial +
1b Oxford 2009 +
Frankling et al. (2021): ‘Palliative-D’ - Vitamin D Supplementation to Palliative Cancer Patients: A Double Blind, Randomized Placebo-Controlled Multicenter Trial +
Level 2 Oxford 2011 +
Freedland et al. (2020): A Randomized Controlled Trial of a 6-month low carbohydrate intervention on disease progression in men with recurrent prostate cancer: Carbohydrate and Prostate Study 2 (CAPS2) +
1b Oxford 2009 +
G
Ghoreishi et al. (2007): Effect of vitamin E on chemotherapy-induced mucositis and neutropenia in leukemic patients undergoing bone marrow transplantation +
1b Oxford 2009 +
Goossens et al. (2016): Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer Trial +
2b Oxford 2009 +
Gorgu et al. (2013): The effect of zinc sulphate in the prevention of radiation induced oral mucositis in patents with head and neck cancer +
2b Oxford 2009 +
Grimison et al. (2020): Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial +
Level 2 Oxford 2011 +
Gujral et al. (2001): Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers +
2b Oxford 2009 +
H
Hajimohammadebrahim-Ketabforoush et al. (2019): Effect of Vitamin D Supplementation on Postcraniotomy Pain After Brain Tumor Surgery: A Randomized Clinical Trial +
Level 2 Oxford 2011 +
Halyard et al. (2007): Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4) +
2b Oxford 2009 +
Showing 1 related entity.
{ "type": "PROPERTY_CONSTRAINT_SCHEMA", "constraints": { "type_constraint": "_txt", "allowed_values": [ "1a Oxford 2009", "1b Oxford 2009", "1c Oxford 2009", "2a Oxford 2009", "2b Oxford 2009", "2c Oxford 2009", "3a Oxford 2009", "3b Oxford 2009", "4 Oxford 2009", "5 Oxford 2009", "Level 1 Oxford 2011", "Level 2 Oxford 2011", "Level 3 Oxford 2011", "Level 4 Oxford 2011", "Level 5 Oxford 2011", "-", "?" ] } }